PUBLIKACJE

 

2018

  1. Boncler M, Kehrel B, Szewczyk R, Stec-Martyna E, Bednarek R, Brodde M, Watała C. “Oxidation of C-reactive protein by hypochlorous acid leads to the formation of potent platelet activator”. Int J Biol Macromol. 2018, 107(Pt B), 2701-2714.
  2. Wilczynski M, Danielska J, Domanska-Senderowska D, Dzieniecka M, Szymanska B, Malinowski A. „Association of miRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer”. Acta Obstet Gynecol Scand. 2018 May; 97(5):560-569.
  3. Uznańska-Loch B, Wikło K, Kulczycka-Wojdala D, Szymańska B, Chrzanowski Ł, Wierzbowska-Drabik K, Trzos E, Kasprzak JD, Kurpesa M. „Genetic variants in the Polish population of patients with pulmonary arterial hypertension - sequencing of BMPR2, ALK1 and ENG genes”. Kardiol Pol. 2018, 76(5):852-859.
  4. Wilczyński M, Żytko E, Danielska J, Szymańska B, Dzieniecka M, Nowak M, Malinowski J, Owczarek D, Wilczyński JR. „Clinical significance of miRNA-21, -103, -129, -150 in serous ovarian cancer”. Arch Gynecol Obstet. 2018 Mar; 297(3):741-748.
  5. Niedźwiecki S, Piekarski J, Szymańska B. Pawłowska Z, Jeziorski A. Serum levels of circulating miRNA-21, miRNA-10b and miRNA-200c in triple-negative breast cancer patients. Ginekol Pol 2018;89(8):415-420.
  6. Majewski S., Tworek, D., Szewczyk K., Kurmanowska Z., Kiszałkiewicz J., Brzeziańska-Lasota E., Jerczyńska H., Antczak A., Piotrowski WJ., Górski P. Overexpression of chitotriosidase and YKL-40 in serum and sputum of healthy smokers and patients with chronic obstructive pulmonary disease. ERS International Congress, Paris, France 15-19 September 2018.
  7. Długosz A, Gach-Janczak K, Szymanski J, Deredas D, Krawczyk H, Janecki T, Janecka A. Anticancer Properties of a New Hybrid Analog AD-013 Combining a Coumarin Scaffold with an α-methylene-δ-lactone Motif. Anticancer Agents Med Chem. 2018;18(3):450-457.
  8. Długosz A, Gach-Janczak K, Szymański J, Deredas D, Janecki T, Janecka A. Involvement of α-methylene-γ- and δ-lactones in the suppression of multidrug resistance in MCF-7 cells. Pharmacol Rep. 2018 Aug;70(4):631-638.

2017

  1. Papiewska-Pająk I, Balcerczyk A, Stec-Martyna E, Koziołkiewicz W, Boncela J. Vascular endothelial growth factor-D modulates oxidant-antioxidant balance of human vascular endothelial cells. J Cell Mol Med. 2017 Jun;21(6):1139-1149.
  2. Długosz A, Gach K, Szymański J, Modranka J, Janecki T, Janecka A. Anticancer activity of new molecular hybrids combining 1,4-naphthalenedione motif with phosphonic acid moiety in hepatocellular carcinoma HepG2 cells. Acta Biochim Pol. 2017;64(1):41-48.
  3. Berent D., Emilien G., Podgorski M., Kusideł E., Kulczycka-Wojdala D., Szymańska B., Macander M., Pawłowska Z. SSTR4, childhood adversity, self-efficacy and suicide risk in alcoholics. Translational Neuroscience, 8, 76-86 (2017).
  4. Drobnik J, Pietrucha K, Kudzin M, Mader K, Szymański J, Szczepanowska A. Comparison of various types of collagenous scaffolds applied for embryonic nerve cell culture. Biologicals. 2017 Mar;46:74-80.
  5. Drobnik J, Pietrucha K, Piera L, Szymański J, Szczepanowska A. Collagenous scaffolds supplemented with hyaluronic acid and chondroitin sulfate used for wound fibroblast and embryonic nerve cell culture. Adv Clin Exp Med. 2017;26(2):223–230.
  6. Księżakowska-Łakoma K, Kulczycka-Wojdala D, Kulig A, Baum M, Wilczyński JR. The presence of A5935G, G5949A, G6081A, G6267A, T9540C mutations in MT-CO1 and MT-CO3 genes and other variants of MT-CO1 and MT-CO3 gene fragments in the study population diagnosed with endometrial cancer. Ginekol Pol. 2017;88(7): 343-348.
  7. Owczarek K, Hrabec E, Fichna J, Sosnowska D, Koziołkiewicz M, Szymański J, Lewandowska U. Flavanols from Japanese quince (Chaenomeles japonica) fruit suppress expression of cyclooxygenase-2, metalloproteinase-9, and nuclear factor-kappaB in human colon cancer cells. Acta Biochimica Polonica. 2017; vol 64(3): 567 – 576.
  8. Wilczyński M, Żytko E, Szymańska B, Dzieniecka M, Nowak M, Danielska J, Stachowiak G, Wilczyński JR. Expression of miR-146a in patients with ovarian cancer and its clinical significance. Oncology Letters. 2017 14: 3207-3214.
  9. Długosz A, Gach-Janczak K, Szymański J, Deredas D, Krawczyk H, Janecki T, Janecka A. Anticancer properties of a new hybrid analog AD-013 combining a coumarin scaffold with an α-methylene-δ-lactone motif. Anticancer Agents Med Chem. 2017.
  10. Berent D., Podgorski M., Kulczycka-Wojdala D., Kusideł E., Macander M., Pawłowska Z. Childhood adversities are not a predictors of SSTR4met in alcoholics. Translational Neuroscience. 2017; 8: 127-138.

2016

  1. Kassassir H., Siewiera K., Talar M., Stec-Martyna E.,  Pawlowska Z., Watala C.: Non-enzymatic modifications of prostaglandin H synthase 1 affect bifunctional enzyme activity - Implications for the sensitivity of blood platelets to acetylsalicylic acid. Chemico-Biological Interactions, 253, 78-92 (2016).
  2. Gach K, Modranka J, Szymański J, Pomorska D, Krajewska U, Mirowski M, Janecki T, Janecka A. Anticancer properties of new synthetic hybrid molecules combining naphtho[2,3-b]furan-4,9-dione or benzo[f]indole-4,9-dione motif with phosphonate subunit. Eur J Med Chem. 2016 Sep 14;120:51-63.
  3. Gach K, Grądzka I, Wasyk I, Męczyńska-Wielgosz S, Iwaneńko T, Szymański J, Koszuk J, Janecki T, Kruszewski M, Janecka A. Anticancer activity and radiosensitization effect of methyleneisoxazolidin-5-ones in hepatocellular carcinoma HepG2 cells. Chem Biol Interact. 2016 Mar 25;248:68-73.
  4. Błaszczak-Świątkiewicz K, Sikora J, Szymański J, Danilewicz M, Mikiciuk-Olasik E. Erratum to: Biological evaluation of the toxicity and the cell cycle interruption by some benzimidazole derivatives. Tumour Biol. 2016 Jun;37(6):8467-8468.
  5. Błaszczak-Świątkiewicz K, Sikora J, Szymański J, Danilewicz M, Mikiciuk-Olasik E. Biological evaluation of the toxicity and the cell cycle interruption by some benzimidazole derivatives. Tumour Biol. 2016 Aug;37(8):11135-45.
  6. Zawlik I, Gablo N, Szymańska B, Pawlowska Z, Chudobinski C, Chalubinska-Fendler J, Morawiec Z, Zielinska-Blizniewska H, Morawiec-Sztandera A, Kolacinska A. Immune checkpoints in aggressive breast cancer subtypes. Neoplasma. 63(5):768-73 (2016).
  7. Wójcik K, Piekarska A, Szymańska B, Jabłonowska E. Hepatic expression of miR-122 and antioxidant genes in patients with chronic hepatitis B. Acta Biochim Pol. 2016 Jul.
  8. Wilczynski M, Danielska J, Dzieniecka M, Szymanska B, Wojciechowski M, Malinowski A. Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer. PLoS One. 2016 Oct 13;11(10):e0164687. doi: 10.1371/journal.pone.0164687

2015

  1. Gach K, Szymański J, Pomorska D, Długosz A, Modranka J, Janecki T, Janecka A. Combined effects of anticancer drugs and new synthetic α-methylene-δ-lactones on MCF-7 cells. Tumor Biol. 2015, Aug;36(8):5971-7.
  2. Kolacinska A., Cebula-Obrzut B., Pakula L., Chalubinska-Fendler J., Morawiec-Sztandera A., Pawlowska Z., Zawlik I., Morawiec Z., Jesionek-Kupnicka D., Smolewski P. „Immune checkpoints in breast cancer surgery”. Oncology Letters, 10(2): 1079-1086 (2015).
  3. Pawelczyk T, Szymanska B, Grancow-Grabka M, Kotlicka-Antczak M, Pawelczyk A. Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia. Neuropsychiatr Dis Treat. 2015, Jun 22;11:1493-503.
  4. Gach K, Szymański J, Pomorska D, Długosz A, Modranka J, Michalak M, Janecki T, Janecka A. Anticancer Properties of Novel 4-methylene-1,2-diphenylpyrazolidin-3-ones. Chem Biol Drug Des. 2015, Nov;86(5):961-8.

2014

  1. Jabłonowska E, Wójcik K, Koślińska-Berkan E, Szymańska B, Omulecka A, Piekarska A. Expression of selected genes in liver biopsy specimens in relation to early virological response in patients with chronic hepatitis C with HCV mono- and HIV/HCV co-infection. Arch Virol. 2014, Jun;159(6):1365-71.
  2. Kolacinska A, Morawiec J, Fendler W, Malachowska B, Morawiec Z, Szemraj J, Pawlowska Z, Chowdhury D, Choi YE, Kubiak R, Pakula L, Zawlik I. „Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report”. Mol Biol Rep. 2014 May;41(5):2851-7.
  3. Olszewska P, Szymański J, Mikiciuk-Olasik E, Szymański P. New cyclopentaquinoline derivatives with fluorobenzoic acid induce G1 arrest and apoptosis in human lung adenocarcinoma cells. Eur J Pharmacol. 2014 Apr 15, 729:30-6.
  4. Wyrebska A., Pawlowska Z., Gach K., Komorowski P., Protas A., Walkowiak B., Janecka A.  Proteomic Analysis of Proteins Engaged in α-Methylene-δ-Lactone Cytotoxic Effects in Hormone-Independent Breast Cancer MDA-MB-231 Cells. Chemical Biology & Drug Design. 2014 Sep;84(3):300-306.
  5. Kolacinska A, Morawiec J, Pawlowska Z, Szemraj J, Szymanska B, Małachowska B, Morawiec Z, Pakula L, Kubiak R, Zawlik I. Association of microRNA-93, 190, 200b and receptor status in core biopsies from stage III breast cancer patients. DNA and Cell Biology, May 17 (2014).
  6. Jabłonowska E, Wójcik K, Szymańska B, Omulecka A, Cwiklińska H, Piekarska A. Hepatic HMOX1 Expression Positively Correlates with Bach-1 and miR-122 in Patients with HCV Mono and HIV/HCV Coinfection. PLoS One. 2014 Apr 21, 9(4):e95564. doi: 10.1371.
  7. Babinska A, Clement CC, Swiatkowska M, Szymanski J, Shon A, Ehrlich YH, Kornecki E, Salifu MO. Development of new anti-atherosclerotic and anti-thrombotic drugs utilizing F11 receptor (F11R/JAM-A) peptides. Biopolymers. 2014 May 7. doi: 10.1002/bip.22503.
  8. Olszewska P, Mikiciuk-Olasik E, Błaszczak-Świątkiewicz K, Szymański J, Szymański P. Novel tetrahydroacridine derivatives inhibit human lung adenocarcinoma cell growth by inducing G1 phase cell cycle arrest and apoptosis. Biomed Pharmacother. 2014 Oct; 68(8):959-67.

2013

  1. Jesionek-Kupnicka D, Szybka M, Potemski P, Kulczycka-Wojdala D, Jaskólski D, Bieńkowski M, Skowroński W, Papierz W, Kordek R, Zawlik I. Association of loss of heterozygosity with shorter survival in primary glioblastoma patients. Pol J Pathol. 2013, 64(4):268-75.
  2. Stawski R, Piaskowski S., Ewelina Stoczynska-Fidelusa, Bieńkowski Ma, Zakrzewska Ma, Och Wc, Jaskólski DJb, Papierz WC, Sikorska Ba, Rieske Pa Liberski PP. Reduced expression of ELAVL4 in male meningioma patients.. Brain Tumor Pathol. 2013, 30(3):160-6.
  3. Matysiak M, Fortak-Michalska M, Szymanska B, Orlowski W, Jurewicz A, Selmaj K. MicroRNA-146a Negatively Regulates the Immunoregulatory Activity of Bone Marrow Stem Cells by Targeting Prostaglandin E2 Synthase-2. J Immunol. 2013, 190(10):5102-5109.
  4. Wyrębska A, Gach K, Lewandowska U, Szewczyk K, Hrabec E, Modranka J, Jakubowski R, Janecki T, Szymański J, Janecka A. Anticancer Activity of New Synthetic α-Methylene-δ-Lactones on Two Breast Cancer Cell Lines. Basic Clin Pharmacol Toxicol. 2013 Aug 19. doi: 10.1111/bcpt.12120.
  5. Wyrebska A, Szymanski J, Gach K, Piekielna J, Koszuk J, Janecki T, Janecka A. Apoptosis-mediated cytotoxic effects of parthenolide and the new synthetic analog MZ-6 on two breast cancer cell lines. Mol Biol Rep. 2013, 40(2):1655–1663.
 

2012

  1. Jabłonowska E, Piekarska A, Koślińska-Berkan E, Omulecka A, Szymańska B, Wójcik K. Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin. Acta Biochim Pol. 2012, 59(3):333-7.
  2. Kolacinska A., Fendler W., Szemraj J., Szymanska B., Borowska-Garganisz E., Nowik M., Chalubinska J., Kubiak R., Pawlowska Z., Blasinska-Morawiec M., Potemski P., Jeziorski A., Morawiec Z. “Gene expression and pathologic response to neoadjuvant chemotherapy in breast cancer” Mol Biol Rep.  2012, 39(7): 7435-41.
  3. Stec-Martyna E, Ponassi M, Miele M, Parodi S, Felli L, Rosano C. Structural comparison of the interaction of tubulin with various ligands affecting microtubule dynamics. Curr Cancer Drug Targets. 2012, 12(6):658-66.
  4. Kolacinska A, Chalubinska J, Zawlik I, Szymanska B, Borowska-Garganisz E, Nowik M, Fendler W, Kubiak R, Pawlowska Z, Morawiec Z, Szemraj J.”Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer” Neoplasma. 2012, 59(4):424-32.

 

2011

  1. Witusik-Perkowska M, Rieske P, Hułas-Bigoszewska K, Zakrzewska M, Stawski R, Kulczycka-Wojdala D, Bieńkowski M, Stoczyńska-Fidelus E, Grešner SM, Piaskowski S, Jaskólski DJ, Papierz W, Zakrzewski K, Kolasa M, Ironside JW, Liberski PP. Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies. J Neurooncol. 2011, 102(3):395-407.  
  2. Boncler M, Rywaniak J, Szymański J, Potempa LA, Rychlik B, Watała C. Modified C-reactive protein interacts with platelet glycoprotein Ibα. Pharmacol Rep. 2011, 63(2):464-75.
  3. Walkowiak B, Szymanski W, Szymanski J, Walczynska M, Walkowiak-Przybylo M, Komorowski P, Okroj W, Jakubowski W, Kaminska M. SPR biosensors technique supports development in biomaterials engineering. New Perspectives in Biosensors Technology and Applications. 2011, ISBN 978-953-307-448-1.  
  4. Condorelli F, Stec-Martyna E, Zaborowska J, Felli L, Gemmi I, Ponassi M, Rosano C.Role of the non-receptor tyrosine kinase fes in cancer. Curr Med Chem. 2011, 18(19):2913-20.
  5. Rosano C, Stec-Martyna E, Lappano R, Maggiolini M.Structure-based approach for the discovery of novel selective estrogen receptor modulators.Curr Med Chem. 2011, 18(8):1188-94.
  6. Gresner SM, Golanska E, Kulczycka-Wojdala D, Jaskolski DJ, Papierz W, Liberski PP. Selection of reference genes for gene expression studies in astrocytomas. Anal Biochem. 2011, 408(1):163-5.
  7. Witusik-Perkowska M, Rieske P, Hułas-Bigoszewska K, Zakrzewska M, Stawski R, Kulczycka-Wojdala D, Bieńkowski M, Stoczyńska-Fidelus E, Grešner SM, Piaskowski S, Jaskólski DJ, Papierz W, Zakrzewski K, Kolasa M, Ironside JW, Liberski PP. Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies.  J. Neurooncol. 2011, 102(3):395-407.
  8. Nobusawa S, Stawski R, Kim YH, Nakazato Y, Ohgaki H. Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study. Neuropathology. 2011, 31(6):583-8.  
  9. Piaskowski S, Bienkowski M, Stoczynska-Fidelus E, Stawski R, Sieruta M, Szybka M, Papierz W, Wolanczyk M, Jaskolski DJ, Liberski PP, Rieske P. Glioma cells showing IDH1 mutation cannot be propagated in standard cell culture conditions. Br J Cancer. 2011, 104(6):968-70.

2010

  1. Ćwiklińska H, Mycko M, Szymańska B, Matysiak M, Selmaj K. „Aberrant stress-induced Hsp70 expression in immune cells in multiple sclerosis”. J Neurosci Res. 2010, 88(14), 3102-3110.
  2. Piaskowski S, Zawlik I, Szybka M, Kulczycka-Wojdala D, Stoczyńska-Fidelus E, Bieńkowski M, Robak T, Kusińska R, Jesionek-Kupnicka D, Kordek R, Rieske P, Liberski P. „Detection of P53 mutations in different cancer types is improved by cDNA sequencing”. Oncology Letters. 2010, 1, 717-721.